#Roche has abandoned the development of one of its #obesity candidates, #emugrobart, and returned rights to originator #ChugaiPharma.
@pharmaphorum.bsky.socialExplore
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#Roche has abandoned the development of one of its #obesity candidates, #emugrobart, and returned rights to originator #ChugaiPharma.